These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27221369)

  • 1. Effects of cooling rate in microscale and pilot scale freeze-drying - Variations in excipient polymorphs and protein secondary structure.
    Peters BH; Staels L; Rantanen J; Molnár F; De Beer T; Lehto VP; Ketolainen J
    Eur J Pharm Sci; 2016 Dec; 95():72-81. PubMed ID: 27221369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Microscale and Pilot-Scale Freeze-Drying on Protein Secondary Structures: Sucrose Formulations of Lysozyme and Catalase.
    Peters BH; Leskinen JTT; Molnár F; Ketolainen J
    J Pharm Sci; 2015 Nov; 104(11):3710-3721. PubMed ID: 26305147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microscale freeze-drying with Raman spectroscopy as a tool for process development.
    Kauppinen A; Toiviainen M; Aaltonen J; Korhonen O; Järvinen K; Juuti M; Pellinen R; Ketolainen J
    Anal Chem; 2013 Feb; 85(4):2109-16. PubMed ID: 23320922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.
    Jena S; Horn J; Suryanarayanan R; Friess W; Aksan A
    Pharm Res; 2017 Feb; 34(2):462-478. PubMed ID: 27981449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
    Al-Hussein A; Gieseler H
    J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
    Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL
    J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannitol/l-Arginine-Based Formulation Systems for Freeze Drying of Protein Pharmaceuticals: Effect of the l-Arginine Counter Ion and Formulation Composition on the Formulation Properties and the Physical State of Mannitol.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2016 Oct; 105(10):3123-3135. PubMed ID: 27506270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of ethanol on physical state of freeze-dried mannitol.
    Takada A; Nail SL; Yonese M
    Pharm Res; 2009 May; 26(5):1112-20. PubMed ID: 19184373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannitol as an Excipient for Lyophilized Injectable Formulations.
    Thakral S; Sonje J; Munjal B; Bhatnagar B; Suryanarayanan R
    J Pharm Sci; 2023 Jan; 112(1):19-35. PubMed ID: 36030846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naproxen Microparticulate Systems Prepared Using In Situ Crystallisation and Freeze-Drying Techniques.
    Solaiman A; Tatari AK; Elkordy AA
    AAPS PharmSciTech; 2017 Jul; 18(5):1438-1446. PubMed ID: 28004343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Well-plate freeze-drying: a high throughput platform for screening of physical properties of freeze-dried formulations.
    Trnka H; Rantanen J; Grohganz H
    Pharm Dev Technol; 2015 Jan; 20(1):65-73. PubMed ID: 24417680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution enhancement of cefdinir with hydroxypropyl-β-cyclodextrin.
    Guo B; Zhong S; Li N; Li X; Yi J; Jin M
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1638-43. PubMed ID: 24087855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
    Grohganz H; Lee YY; Rantanen J; Yang M
    Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystallizing amino acids as bulking agents in freeze-drying.
    Horn J; Tolardo E; Fissore D; Friess W
    Eur J Pharm Biopharm; 2018 Nov; 132():70-82. PubMed ID: 30201570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis.
    Pralhad T; Rajendrakumar K
    J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of formulation and process factors on the crystal structure of freeze-dried Myo-inositol.
    Izutsu K; Yomota C; Okuda H; Kawanishi T; Yamaki T; Ohdate R; Yu Z; Yonemochi E; Terada K
    J Pharm Sci; 2014 Aug; 103(8):2347-55. PubMed ID: 24916801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural attributes of model protein formulations prepared by rapid freeze-drying cycles in a microscale heating stage.
    Peters BH; Molnár F; Ketolainen J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):347-56. PubMed ID: 24607807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of docetaxel solubility using binary and ternary solid dispersion systems.
    Lim SM; Pang ZW; Tan HY; Shaikh M; Adinarayana G; Garg S
    Drug Dev Ind Pharm; 2015; 41(11):1847-55. PubMed ID: 25721984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.